TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Dutruel, CélineThole, Jelle
Geels, Mark
Mollenkopf, Hans-Joachim
Ottenhoff, Tom
Guzman, Carlos A
Fletcher, Helen A
Leroy, Odile
Kaufmann, Stefan H E
Issue Date
2014-07-31
Metadata
Show full item recordAbstract
High-throughput analyses of RNA and protein expression are increasingly used for better understanding of vaccine-induced immunity and protection against infectious disease. With an increasing number of vaccine candidates in clinical development, it is timely to consider standardisation and harmonisation of sample collection, storage and analysis to ensure results of highest quality from these precious samples. These challenges were discussed by a group of international experts during a workshop organised by TRANSVAC, a European Commission-funded Research Infrastructure project. The main conclusions were: Platforms are rarely standardised for use in preclinical and clinical studies. Coordinated efforts should continue to harmonise the experimental set up of these studies, as well as the establishment of internal standards and controls. This will ensure comparability, efficiency and feasibility of the global analyses performed on preclinical and clinical data sets.Citation
TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'. 2014, 32 (35):4365-8 VaccineAffiliation
Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.Journal
VaccinePubMed ID
24950356Type
ArticleLanguage
enISSN
1873-2518ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2014.06.014
Scopus Count
The following license files are associated with this item:
Related articles
- Infectious disease: Beating the big three.
- Authors: Bourzac K
- Issue date: 2014 Mar 6
- A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design.
- Authors: D'Argenio DA, Wilson CB
- Issue date: 2010 Oct 29
- A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus.
- Authors: Tamminga C, Kavanaugh M, Fedders C, Maiolatesi S, Abraham N, Bonhoeffer J, Heininger U, Vasquez CS, Moorthy VS, Epstein JE, Richie TL
- Issue date: 2013 Aug 2
- A 2020 vision for vaccines against HIV, tuberculosis and malaria.
- Authors: Rappuoli R, Aderem A
- Issue date: 2011 May 26
- Next generation of human vaccines: what does the future hold?
- Authors: Awasthi S
- Issue date: 2008 Sep-Oct